Botanical extract (mixture) · Fact sheet

Ashwagandha

Also known as Withania somnifera

Ashwagandha is a botanical extract with small trials suggesting stress and sleep benefits. Preparations vary, and drowsiness, gastrointestinal effects, thyroid concerns, and rare liver-injury reports complicate broad wellness claims.

Not FDA approvedEarly human evidence

What is Ashwagandha?

Ashwagandha is a plant, not a single molecule or peptide. Root and leaf preparations contain mixtures of constituents, so product-specific results should not be assigned to all extracts.

Benefits & claims

Stress relief, sleep, lower cortisol, and testosterone-related claims are common. A change in a stress questionnaire or hormone does not establish benefit for every associated condition.

What the evidence supports

  • Some short trials suggest improvements in stress or sleep with specific preparations.
  • Evidence does not establish a universal anxiety treatment, reliable hormonal enhancement, or long-term safety.
Research areas
  • Perceived stress
  • Sleep
  • Stress-related hormone measures

Dosage & frequency

Human study context

A stress trial used a defined root extract. That research amount cannot be assumed to apply to generic root powder or all commercial extracts.

Randomized chronic-stress trial

64 adults reporting chronic stress

Amount
300 mg full-spectrum root extract per dose
Frequency
Twice daily for 60 days
Route studied or labeled
Oral

Defined extract and stress measures; not interchangeable with generic powders.

How to read these amounts

An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.

Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences

Formulations, interactions & practical context

Formulation differences

  • Root-only and root-plus-leaf extracts can differ in constituents and concentration.

Interactions & precautions

  • NCCIH flags possible interactions with thyroid hormone, sedatives, immunosuppressants, and medicines for diabetes or blood pressure.

What is still unresolved

  • Long-term safety and effects across different extracts are uncertain.

Side effects & risks

  • Drowsiness, stomach upset, diarrhea, and vomiting are possible.
  • Published case reports describe liver injury; they do not measure how often it occurs.
  • Thyroid, autoimmune, pregnancy, and medication-interaction concerns are described by NCCIH.

This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.

Clinical research

Early human evidence

A 64-person trial found lower stress scores with a particular root extract over 60 days. Small samples, varied preparations, and short follow-up limit generalization.

Studies

Personal experiences

Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.

Explore 3 sourced accounts by reported effect.

Energy: reported experiences

Mixed account · personal report

Early calm followed by emotional flatness

An author described less stress at first, then loss of joy, motivation and sexual interest over several months. They reported some improvement a week after stopping.

Reported use in this account

Product
Ashwagandha supplement; extract or whole-root formulation not stated
Amount
3,600 mg
Frequency
Daily
Route
Not specified clearly
Duration
About five months

This self-assessment does not establish a clinical diagnosis, causation or permanent effects.

Read the original account

Approval status

Ashwagandha has no FDA-approved drug indication for the wellness uses discussed here. Supplement availability is not premarket FDA approval of effectiveness or safety.

Supplement research is not FDA drug approval

Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.

Open questions

  • Which preparations reproduce trial results
  • Long-term safety and the frequency of liver injury
  • Meaningful hormonal or functional outcomes

Summary

Evidence does not establish a universal anxiety treatment, reliable hormonal enhancement, or long-term safety.

Sources

Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.

  1. pubmedAshwagandha root extract and stress

    64-person, 60-day randomized trial of a specific extract.

  2. nihNCCIH: ashwagandha usefulness and safety

    Evidence limitations, gastrointestinal effects, and condition-specific safety concerns.

  3. pubmedAshwagandha-associated liver injury case series

    Five clinical cases; causality assessment, co-exposures, and follow-up limitations.

How we assess sources · Suggest a correction